These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39028735)

  • 1. High rates of deferring antiretroviral treatment for patients with HIV and substance use disorders: Results from a national sample of HIV physicians in Ukraine.
    Ottesen TD; Wickersham JA; Lawrence JC; Antoniak S; Zezuilin O; Polonsky M; Antonyak S; Rozanova J; Dvoriak S; Pykalo I; Filippovych M; Altice FL
    PLoS One; 2024; 19(7):e0305086. PubMed ID: 39028735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia.
    Ferro EG; Culbert GJ; Wickersham JA; Marcus R; Steffen AD; Pauls HA; Westergaard RP; Lee CK; Kamarulzaman A; Altice FL
    Open Forum Infect Dis; 2017; 4(1):ofw219. PubMed ID: 28480230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.
    Westergaard RP; Ambrose BK; Mehta SH; Kirk GD
    J Int AIDS Soc; 2012 Feb; 15(1):10. PubMed ID: 22360788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
    Lancaster KE; Hoffman IF; Hanscom B; Ha TV; Dumchev K; Susami H; Rose S; Go VF; Reifeis SA; Mollan KR; Hudgens MG; Piwowar-Manning EM; Richardson P; Dvoriak S; Djoerban Z; Kiriazova T; Zeziulin O; Djauzi S; Ahn CV; Latkin C; Metzger D; Burns DN; Sugarman J; Strathdee SA; Eshleman SH; Clarke W; Donnell D; Emel L; Sunner LE; McKinstry L; Sista N; Hamilton EL; Lucas JP; Duong BD; Van Vuong N; Sarasvita R; Miller WC;
    J Int AIDS Soc; 2018 Oct; 21(10):e25195. PubMed ID: 30350406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians.
    Krakower DS; Beekmann SE; Polgreen PM; Mayer KH
    Clin Infect Dis; 2016 Jan; 62(1):99-105. PubMed ID: 26385993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in provider-advised HIV antiretroviral therapy deferral in the United States, 2009-2014.
    Beer L; Weiser J; Luke Shouse R
    AIDS Care; 2019 Jul; 31(7):821-826. PubMed ID: 30466314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
    BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.
    Hoehn N; Gill MJ; Krentz HB
    AIDS Care; 2017 May; 29(5):564-569. PubMed ID: 27642701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
    Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
    AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.
    Saleem HT; Mushi D; Hassan S; Bruce RD; Cooke A; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():59-65. PubMed ID: 26831364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].
    Viciana-Fernández P; Falcó V; Castaño M; de los Santos-Gil I; Olalla-Sierra J; Hernando A; Deig E; Clotet B; Knobel H; Podzamczer D; Pedrol PD;
    Enferm Infecc Microbiol Clin; 2015; 33(6):397-403. PubMed ID: 25577557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
    Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
    Chammartin F; Lodi S; Logan R; Ryom L; Mocroft A; Kirk O; d'Arminio Monforte A; Reiss P; Phillips A; El-Sadr W; Hatleberg CI; Pradier C; Bonnet F; Law M; De Wit S; Sabin C; Lundgren JD; Bucher HC;
    Ann Intern Med; 2021 Jun; 174(6):768-776. PubMed ID: 33721519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
    Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
    Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
    Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
    Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala.
    Mbonye M; Seeley J; Nalugya R; Kiwanuka T; Bagiire D; Mugyenyi M; Namale G; Mayanja Y; Kamali A
    AIDS Care; 2016; 28 Suppl 3():33-8. PubMed ID: 27421050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia.
    Bovell-Ammon BJ; Kimmel SD; Cheng DM; Truong V; Michals A; Vetrova M; Hook K; Idrisov B; Blokhina E; Krupitsky E; Samet JH; Lunze K
    Int J Drug Policy; 2023 Jan; 111():103907. PubMed ID: 36402082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.